Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population
NCT04875520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1390
Last updated 2026-06-29
Summary
The primary goal of this study is to determine the most effective SARS-CoV-2 testing strategy for successful return of in-person school in the under-served communities of St. Louis.
Regular screening testing has been recommended by the CDC as an additive mitigation strategy for in-person schools in areas of high community transmission. We will compare the effectiveness and acceptance of two different school-based testing strategies among students and school staff (symptomatic testing only versus weekly surveillance testing plus symptomatic testing), measuring school-based SARS-CoV-2 transmission through a cluster randomized trial.
Conditions
- Covid19
Interventions
- OTHER
-
Screening testing strategy
The intervention we are evaluating is the use of weekly screening testing among students and staff.
- OTHER
-
No screening testing strategy
a group of schools will not receive screening testing.
Sponsors & Collaborators
-
Washington University School of Medicine
lead OTHER
Principal Investigators
-
Jason G. Newland, MD · Washington University School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-07
- Primary Completion
- 2023-05-31
- Completion
- 2023-12-31
Countries
- United States
Study Locations
More Related Trials
-
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels
NCT03731169 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
NCT06819410 ·Status: RECRUITING
-
An Observational Study of Fungal Biomarkers (MK-0000-089)
NCT00854607 ·Status: COMPLETED
-
Caspofungin Acetate in Treating Children With Fever and Neutropenia
NCT00020527 ·Status: COMPLETED ·Phase: NA
-
Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin
NCT03857399 ·Status: COMPLETED ·Phase: PHASE2
-
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
NCT00723073 ·Status: COMPLETED
-
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
NCT02678598 ·Status: COMPLETED
-
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis
NCT00665639 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy
NCT02895529 ·Status: TERMINATED ·Phase: PHASE4
-
To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantation
NCT04728971 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Azole Susceptibility and Resistance Mechanisms Surveys in Pathogenic Fungi by the CARST-fungi (2023-2024)
NCT06969703 ·Status: NOT_YET_RECRUITING
-
Changing Patterns of Candida Infections in Urban Medical Centers
NCT00366223 ·Status: COMPLETED
-
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)
NCT00082537 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)
NCT00250432 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy
NCT04238884 ·Status: UNKNOWN ·Phase: PHASE4
-
Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)
NCT00292071 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection
NCT00001702 ·Status: COMPLETED
-
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)
NCT00083343 ·Status: COMPLETED ·Phase: PHASE2
-
Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal Infections
NCT00876096 ·Status: COMPLETED ·Phase: NA
-
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
NCT00841971 ·Status: COMPLETED ·Phase: PHASE4
-
Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis
NCT02646774 ·Status: TERMINATED ·Phase: PHASE4
-
Micafungin Salvage Mono-therapy in Invasive Aspergillosis
NCT00376337 ·Status: TERMINATED ·Phase: PHASE2
-
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis
NCT00923832 ·Status: COMPLETED
-
The Impact of Rapid Diagnostic Methods in the Diagnosis of Fungal Infections in Intensive Care Units of Assiut University Hospital
NCT05876962 ·Status: UNKNOWN
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA